United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

$ 1,050$ 1,650

Published Date: June, 2019

Content info: 95 pages

Region: United States

Published By: DPI Research

Clear

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025.

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025 presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up–to–date industry data on the actual market situation and future outlook for United States pneumococcal & meningococcal vaccines market. The report includes historical data from 2015 to 2018 and forecasts until 2025.

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025. The report provides clear insight into current and future developments of the United States pneumococcal & meningococcal vaccines market. The report also explores detailed analysis of top 6 vaccines market assessment in United States from 2015 to 2018 and forecasts to 2025. The report also details the latest information about the pneumococcal & meningococcal vaccines pricing trends and analysis. It also covers reimbursement pattern and offers a clear view of the regulatory landscape.

Additionally, the report includes assessment of promising vaccines in the clinical development by major companies. Key trends in terms of collaboration, merger & acquisition, distribution, exclusive, licensing agreement and partnerships are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the United States pneumococcal & meningococcal vaccines market.

The report concludes with the profiles of major players in the United States pneumococcal & meningococcal vaccines market. The key market players are evaluated on various parameters such as business overview, vaccines portfolio and recent development.

The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:

Pfizer, Merck, Sanofi Pasteur and GlaxoSmithKline (GSK)

Top 6 Vaccines Covered Under This Report Are:

  • Prevnar / Prevnar 13
  • Pneumovax 23
  • Menactra
  • Bexsero
  • Menveo
  • Trumenba

The Latest Industry Data Included in this Report:

  • United States Pneumococcal & Meningococcal Vaccines Market Size & Analysis (2015 – 2025)
  • United States Pneumococcal Vaccines Market Size & Analysis (2015 – 2025)
  • United States Meningococcal Vaccines Market Size & Analysis (2015 – 2025)
  • United States Pneumococcal & Meningococcal Vaccines Market Share & Y–o–Y Growth (%), 2017 – 2025
  • United States Pneumococcal Vaccines Market Share & Y–o–Y Growth (%), 2015 – 2025
  • United States Meningococcal Vaccines Market Share & Y–o–Y Growth (%), 2017 – 2025
  • United States Pneumococcal & Meningococcal Vaccines Market Assessment & Opportunity (Value),2015 – 2025
  • United States Pneumococcal & Meningococcal Vaccines Pricing Trends & Analysis
  • United States Pneumococcal & Meningococcal Vaccines Reimbursement Policies
  • United States Pneumococcal & Meningococcal Vaccines Regulatory System
  • Promising Pneumococcal & Meningococcal Vaccines in Clinical Development
  • Major Deals in the Vaccines Market
  • Key Drivers and Inhibitors of the United States Pneumococcal & Meningococcal Vaccines Market
  • Major Companies Analysis

The Report Answers the Following Questions about the United States Pneumococcal & Meningococcal Vaccines Market:

  • What is the size of the United States pneumococcal & meningococcal vaccines market during 2015 – 2025?
  • What will be the revenue generated by each vaccine during the forecast period?
  • Which vaccine provides highest market share?
  • How are the overall market and vaccines type growing?
  • What are the key drivers and inhibitors in the current market?
  • What are the various pneumococcal & meningococcal vaccines available in the United States?
  • How is the market predicted to develop in the future?
  • Who are the key players in this market space?
CHOOSE YOUR BUYING OPTION

Enterprise Price, Multi User Price, Single User Price

Table of Contents

1. Executive Summary
2. United States Pneumococcal & Meningococcal Vaccines Market Size & Analysis (2015 – 2025)
3. United States Pneumococcal Vaccines Market Size & Analysis (2015 – 2025)
4. United States Meningococcal Vaccines Market Size & Analysis (2015 – 2025)
5. United States Pneumococcal & Meningococcal Vaccines Market Share & Y–o–Y Growth (%), 2017 – 2025
5.1 United States Pneumococcal Vaccines Market Share & Y–o–Y Growth (%), 2015 – 2025
5.2 United States Meningococcal Vaccines Market Share & Y–o–Y Growth (%), 2017 – 2025
6. Key Drivers and Inhibitors of the United States Pneumococcal & Meningococcal Vaccines Market
6.1 Market Drivers
6.2 Market Inhibitors
7. United States Pneumococcal & Meningococcal Vaccines Market Assessment & Opportunity (Value),2015 – 2025
7.1 Prevnar / Prevnar 13
7.2 Pneumovax 23
7.3 Menactra
7.4 Bexsero
7.5 Menveo
7.6 Trumenba
8. United States Pneumococcal & Meningococcal Vaccines Pricing Trends & Analysis
9. United States Pneumococcal & Meningococcal Vaccines Reimbursement Policies & Regulatory System
9.1 Reimbursement Policies
9.2 Regulation System
10. Promising Pneumococcal & Meningococcal Vaccines in Clinical Development
11. Major Deals in the Vaccines Market
11.1 Merger & Acquisitions
11.2 Collaboration Deals
11.3 Licensing Agreement
11.4 Exclusive Agreement
11.5 Distribution Agreement
11.6 Partnerships
12. Key Companies Analysis
12.1 Sanofi Pasteur
12.1.1 Business Overview
12.1.2 Vaccines Portfolio
12.1.3 Recent Development
12.2 GlaxoSmithKline (GSK)
12.2.1 Business Overview
12.2.2 Vaccines Portfolio
12.2.3 Recent Development
12.3 Merck
12.3.1 Business Overview
12.3.2 Vaccines Portfolio
12.3.3 Recent Development
12.4 Pfizer
12.4.1 Business Overview
12.4.2 Vaccines Portfolio
12.4.3 Recent Development

List of Tables

Table 5–1: United States Pneumococcal & Meningococcal Vaccines Market Share & Y–o–Y Growth (Percent), 2017 – 2018
Table 5–2: United States Pneumococcal & Meningococcal Vaccines Market Share & Y–o–Y Growth Forecast (Percent), 2019 – 2025
Table 5–3: United States Pneumococcal Vaccines Market Share & Y–o–Y Growth (Percent), 2015 – 2018
Table 5–4: United States Pneumococcal Vaccines Market Share & Y–o–Y Growth Forecast (Percent), 2019 – 2025
Table 5–5: United States Meningococcal Vaccines Market Share & Y–o–Y Growth (Percent), 2017 – 2018
Table 5–6: United States Meningococcal Vaccines Market Share & Y–o–Y Growth Forecast (Percent), 2019 – 2025
Table 8–1: United States Pneumococcal & Meningococcal Adult Vaccines Price, 2019 – 2020
Table 8–2: United States Pneumococcal & Meningococcal Pediatric Vaccines Price, 2019 – 2020
Table 9–1: United States Simplified Regulatory Pathway from Preclinical to the Marketing Authorization
Table 11–1: Merger & Acquisitions in the Vaccines Market
Table 11–2: Collaboration Deal in the Vaccines Market
Table 11–3: Licensing Agreement in the Vaccines Market
Table 11–4: Exclusive Agreement in the Vaccines Market
Table 11–5: Distribution Agreement in the Vaccines Market
Table 6–6: Partnerships in the Vaccines Market

List of Figures

Figure 2–1: United States Pneumococcal & Meningococcal Vaccines Market Size(Million US$),2015 – 2018
Figure 2–2: United States Pneumococcal & Meningococcal Vaccines Market Size Forecast(Million US$),2019 – 2025
Figure 3–1: United States Pneumococcal Vaccines Market Size (Million US$),2015 – 2018
Figure 3–2: United States Pneumococcal Vaccines Market Size Forecast (Million US$),2019 – 2025
Figure 4–1: United States Meningococcal Vaccines Market Size (Million US$),2015 – 2018
Figure 4–2: United States Meningococcal Vaccines Market Size Forecast (Million US$),2019 – 2025
Figure 7–1: United States Prevnar/Prevnar 13 Market Value (Million US$),2015 – 2018
Figure 7–2: United States Prevnar/Prevnar 13 Market Value Forecast (Million US$),2019 – 2025
Figure 7–3: United States Pneumovax 23 Market Value (Million US$),2015 – 2018
Figure 7–4: United States Pneumovax 23 Market Value Forecast (Million US$),2019 – 2025
Figure 7–5: United States Menactra Market Value (Million US$),2015 – 2018
Figure 7–6: United States Menactra Market Value Forecast (Million US$),2019 – 2025
Figure 7–7: United States Bexsero Market Value (Million US$),2015 – 2018
Figure 7–8: United States Bexsero Market Value Forecast (Million US$),2019 – 2025
Figure 7–9: United States Menveo Market Value (Million US$),2015 – 2018
Figure 7–10: United States Menveo Market Value Forecast (Million US$),2019 – 2025
Figure 7–11: United States Trumenba Market Value (Million US$),2017 – 2018
Figure 7–12: United States Trumenba Market Value Forecast (Million US$),2019 – 2025

Companies Mentioned

Pfizer

Merck

Sanofi Pasteur

GlaxoSmithKline (GSK)

Reviews

There are no reviews yet.

Be the first to review “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025”

Your email address will not be published. Required fields are marked *